Seed Biotechnology Companies

Rasio Therapeutics is a biopharmaceutical company that develops novel medicines using computer-aided drug design technology.

Muse Bio is a biotechnology research centre that transforms menstrual blood into renewable mesenchymal stem cells.

Ligo Biosciences develops deep-learning models for enzyme design to reduce the cost of chemical manufacturing.

LIFE AI is an AI-powered blockchain platform for decentralized science in genomics, enabling users to own, control, monetize personal data.

The Embryo Corporation is a biotech company that develops new organisms and biological traits using AI-driven genetic engineering.

Biolevate is an AI company that helps healthcare professionals accelerate scientific innovation and improve knowledge management.

Redefining the therapy of severe lung diseases

Female-led Austrian biotech developing STAT5 inhibitors for AML — seed stage

Lytos is a biotech platform company tackling AMR with technologies that disrupt biofilms, kill pathogens, and replace traditional chemicals.

Developing next-generation cardiac regenerative medicine, leveraging AI-driven bioprocessing to transform heart failure treatment

Advanced Biosimulation Technologies is a biosimulation company developing computational biology and mathematical modeling solutions.

Meddenovo Drug Design develops AI-supported solutions to design cyclic peptide therapeutics.

Vyro develops oncolytic viruses designed to target CNS tumors, based on pioneering research on the oncolytic properties of the Zika Virus.

Pioneering novel antibody-based cancer therapies informed by large-scale patient-derived biology.

Syntopa develops precision biologics using our proprietary methods and the latest technologies from Ag Tech and Synthetic Biology.

MesencHyal-T is a biotechnology company that develops cellular medical therapies for the treatment of tissue regeneration.

First-in-class predictive biomarkers to unlock antifibrotic therapy for breast cancer and beyond...

The first invisible feeding tube — intraorally anchored, non-surgical, fully removable.

At 310 AI, our aim is to build the generative AI engine that will make programmable biology a reality.

Eureka Nanobioengineering offers a proprietary platform for the creation of nanobiodevices and advanced functional nanobiomaterials.

Glamorous AI is a developer of an artificial intelligence-based drug discovery platform.

Outer Biosciences is a Bioactives for Skin Health.

Phosphorus provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine.

Avenue Biosciences is a transatlantic biotech business that specializes on innovative protein engineering technologies.

Nanochon develops medical implant technology focused on cartilage repair for patients with joint surface damage.